FDA Adverse Event
Malfunction
Summary report: N
CHLORAPREP ONE STEP
MDR report key: 11947784
·
Received June 7, 2021
Report
- Report Number
- 3004932373-2021-00276
- Event Type
- Malfunction
- Date Received
- June 7, 2021
- Date of Event
- May 12, 2021
- Report Date
- September 7, 2021
- Manufacturer
- CAREFUSION 213, LLC 0113
- Product Code
- KXG
- PMA / PMN Number
- EXEMPT
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- BR
- Reporter Occupation
- 501
Narratives
Additional Manufacturer Narrative · 0
FAILURE MODE WAS NOT CONFIRMED DUE TO NO SAMPLE RECEIVED. THE MOST PROBABLE ROOT CAUSE CAN BE ATTRIBUTED TO POST MANUFACTURING HANDLING, WHICH CAN PROVIDE ENOUGH FORCE/IMPACT TO ACTIVATE AND BREAK THE GLASS AMPOULE. DUE TO THE NATURE OF GLASS, IT IS POSSIBLE TO HAVE AN ACTIVATED APPLICATOR AND/OR BROKEN AMPOULE IF THE APPLICATOR UNDERGOES EXCESSIVE HANDLING.
Description of Event or Problem · 0
WHEN TRYING TO USE THE CHLORAPREP, IT WAS NOTICED THAT ITS CONTENT IS CRYSTALLIZED.
Additional Manufacturer Narrative · 1
(B)(4). INITIAL EMDR SUBMISSION. A FOLLOW UP EMDR WILL BE SUBMITTED IF ADDITIONAL INFORMATION BECOMES AVAILABLE.
Description of Event or Problem · 1
WHEN TRYING TO USE THE CHLORAPREP, IT WAS NOTICED THAT ITS CONTENT IS CRYSTALLIZED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 845342 | CHLORAPREP ONE STEP | 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL | KXG | CAREFUSION 213, LLC 0113 | 0286480 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |